Saint Luke's Newsroom

Oct. 10, 2023
KSHB: Kansas City Woman Starts Fund for Metastatic Breast Cancer Research
KSHB talked to Dr. Tim Pluard about how research is advancing treatment and leading to improved outcomes for Brooke and other women with metastatic breast cancer.
Oct. 9, 2023
KCTV: Medical Providers Encourage Women to Make Mammogram Appointments
Dr. Meierotto talks to KCT V about why women put preventive screenings off and how Saint Luke's is helping make sure patients in rural communities get the same great care as those in the Kansas City metro area.
Medscape logo
Oct. 6, 2023
Medscape: Virtual Nursing Offers a New Career Option for Nurses
Medscape talked to Susie Krug about how virtual nursing is transforming the way Saint Luke's provides care.
Sep. 29, 2023
KMBC: Clearing Up COVID-19 Vaccine Confusion
KMBC talked to Dr. Sarah Boyd about why people should get the new vaccine this fall.
Sep. 29, 2023
HCP Live: Report: More Than 25% of U.S. Adults Has One or More Cardiac, Renal, or Metabolic Conditions
Researchers at Saint Luke's Mid America Heart Institute took part in an analysis examining two decades of trends in the prevalence and overlap of cardiac, renal, and metabolic conditions among U.S. adults.
Sep. 26, 2023
KMBC: Kansas City Current Players Visit Saint Luke's Hospital of Kansas City
The Kansas City Current Teal Mobile and KC Current players made a special visit to Saint Luke's Hospital to hang out and talk with staff to show appreciation.
Sep. 26, 2023
KSHB: Kansas City Current Players Visit Saint Luke's Hospital of Kansas City
The Kansas City Current Teal Mobile and KC Current players made a special visit to Saint Luke's Hospital to hang out and talk with staff to show appreciation.
Sep. 26, 2023
KCTV: Medication vs. Surgery: Making the Right Decision for Lasting Weight Loss Results
KCTV talked to Dr. Rob Kenney about the effectiveness of these medications compared to weight loss surgery and when each of these treatments is most appropriate.
Sep. 21, 2023
Healio: Minimally Symptomatic Patients Likely to Survive with Good Health Status After TAVR
Dr. Chetan Huded and colleagues found patients with minimal symptoms who underwent TAVR were more likely to survive with good health status at one year than more symptomatic patients.